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NLRP3 inflammasome has been implicated in impaired post-injury muscle healing and in
muscle atrophy. Histamine receptors play an important role in inflammation, but the role of
histamine H3 receptor (H3R) in myocyte regeneration and in the regulation of NLRP3
inflammasome is not known. We studied the effects of H3R signaling on C2C12 myocyte
viability, apoptosis, and tumor necrosis factor alpha (TNFα)-induced NLRP3
inflammasome activation during striated myogenic differentiation at three time points
(days 0, 3, and 6). Expression of Nlrp3, interleukin-1β (IL-1β), and myogenesis markers
were determined. TNFα reduced overall viability of C2C12 cells, and exposure to TNFα
induced apoptosis of cells at D6. Activation of H3R had no effect on viability or apoptosis,
whereas inhibition of H3R increased TNFα-induced apoptosis. Stimulation of C2C12 cells
with TNFα increased Nlrp3mRNA expression at D3 and D6. Moreover, TNFα reduced the
expression of myogenesis markers MyoD1, Myogenin, and Myosin-2 at D3 and D6. H3R
attenuated TNFα-induced expression ofNlrp3 and further inhibited themyogenesis marker
expression; while H3R -blockage enhanced the proinflammatory effects of TNFα and
increased the myogenesis marker expression. TNFα-induced secretion of mature IL-1β
was dependent on the activation of the NLRP3 inflammasome, as shown by the reduced
secretion of mature IL-1β upon treatment of the cells with the small molecule inhibitor of the
NLRP3 inflammasome (MCC950). The activation of H3R reduced TNFα-induced IL-1β
secretion, while the H3R blockage had an opposite effect. In conclusion, the modulation of
H3R activity regulates the effects of TNFα on C2C12 myocyte differentiation and TNFα-
induced activation of NLRP3 inflammasome. Thus, H3R signaling may represent a novel
target for limiting postinjury muscle inflammation and muscle atrophy.
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INTRODUCTION
Inflammation can complicate post-injury muscle healing and
slow down the regenerative repair process (Hofer et al., 2014).
However, the factors underlying the post injury inflammation are
poorly known. It is believed that activation of the inflammasomes,
with ensuing production of highly proinflammatory cytokines,
IL-1β and IL-18, may play a key role by initiating the
inflammatory reaction (Mangan et al., 2018). Nucleotide-
binding domain and leucine-rich repeat containing family
(NLR), pyrin domain containing 3 (NLRP3) inflammasome is
themost widely studied inflammasome. It is activated by amyriad
of factors, including exogenous pathogens and endogenous
danger signals, and has been implicated in a variety of
immunological (Mulay et al., 2018) and non-immunological
diseases (Hughes et al., 2016). The NLRP3 inflammasome is a
multi-protein complex, consisting of the sensor protein NLRP3,
apoptosis-associated speck-like protein containing a CARD
(ASC), and the precursor of caspase 1 (pro-caspase-1). Upon
activation, NLRP3 is associated with pro-caspase-1 via the
adaptor protein ASC resulting in autoactivation of pro-
caspase-1 into its active form. The active caspase-1 then
catalyzes the cleavage of the inactive precursors of interleukin
1β (pro-IL-1β) and interleukin 18 (pro-IL-18) into their active
secreted forms, thus triggering the inflammatory storm (Man and
Kanneganti, 2015). NLRP3 inflammasome is mainly expressed in
innate immune cells such as neutrophils, macrophages,
monocytes, and dendritic cells, but low expression levels are
seen in other cell types and tissues (Latz et al., 2013; Elliott
and Sutterwala, 2015; Guo et al., 2015; Jo et al., 2016). NLRP3 has
been shown to be expressed also in myocytes (Wei et al., 2020)
and it has been implicated in the pathogenesis of inflammatory
myopathies (Boursereau et al., 2018).
After exercise, skeletal muscle can secrete many bioactive
molecules, known as myokines, and tumor necrosis factor
alpha (TNFα) is one of the most common exercise-regulated
myokines (also named adipo-myokines) (Görgens et al., 2015),
which can induce autophagy and apoptosis in mouse C2C12
myoblasts and myotubes (Gallo et al., 2015). The inflammation-
associated insulin resistance of C2C12 myoblasts and myotubes
has been suggested to be mediated by the activation of NLRP3
inflammasome (Cho and Kang, 2015).
There are four known histamine receptors, of which histamine
H3 receptor (H3R) is mainly expressed in immune and nerve cells,
and is involved in nerve conduction, muscle contraction,
gastrointestinal neuromodulation, and inflammation (Branco
et al., 2018). We found previously that H3R is expressed in
C2C12 myoblasts and in primary adult mid-urethral striated
muscles (Chen et al., 2015; Chen et al., 2015). In C2C12
myoblasts the expression of H3R was increased during their
myogenic differentiation into striated myocytes, and in myocytes
the activation of the H3R facilitated the relaxation of the cells by
limiting the cytoplasmic calcium peak (Chen et al., 2015). Histamine
and histamine receptors possess immunomodulatory effects (Branco
et al., 2018). Histamine has been reported to dampen the
inflammatory effects of lipopolysaccharides, and in particular,
histamine has been shown to inhibit the secretion of IL-1β in
microglial cells (Barata-Antunes et al., 2017). In present study we
explore further the role of H3R in regulation of myoblast
differentiation and myocyte function. We hypothesized that H3R
could modulate the secretion of IL-1β by regulating the activation of
the NLRP3 inflammasome. By utilizing highly selectiveH3R agonists
(methimepip, Met) (Chen et al., 2015; Panula et al., 2015), and H3R
blocker (ciproxifan, CPX) (Chen et al., 2015; Panula et al., 2015) we
show that activation of H3R signaling mitigates the TNFα-induced
NLRP3 inflammasome activation, and thus H3R signaling could
represent a potential target for treatment in conditions involving
muscle inflammation and inflammation induced muscle atrophy.
EXPERIMENTAL
Materials
The cell culture medium, Dulbecco’s modified Eagle’s medium
(DMEM), was purchased from Biowhittaker/Lonza, penicillin-
streptomycin from Cambrex/Lonza, Glutamine [Gibco®
GlutaMAX™ Supplement (35050061)], and heat inactivated fetal
bovine serum (FBS, 10100147) was from Thermo Fisher Scientific.
The primers were designed and purchased from Sangon Biotech,
China. Mouse IL-1β enzyme-linked immunosorbent assay (ELISA)
Kit (D720335-0096) and recombinant murine TNFα (C600052-
0005) were purchased from Sangon Biotech, China. The Cell
Counting Kit (CCK-8) (C0038) and Annexin V-FITC/propidium
iodide (PI) Apoptosis Detection Kit (C1063) were purchased from
Beyotime Corporation, China. H3R agonist methimepip (Met) (sc-
204080) was from Santa Cruz Corporation, and ciproxifan (CPX)
(C6492), H3R blocker, was from SIGMA Inc. MCC950 (CP-456773,
210826-40-7, AbMole, China) was purchased from AbMole Inc.
Cell Culture
Mouse C2C12 myoblasts were obtained from American Type
Culture Collection, and maintained in DMEM supplemented
with 10% fetal bovine serum (FBS), 1% antibiotics (100 U/ml
penicillin and 100 μg/ml streptomycin (GIBCO #15140-122), and
glutamine at 37°C in humidified 5% CO2-in-air. In the
differentiation medium, FBS was reduced from 10 to 1%, but
otherwise the differentiation medium had the same composition
as the growthmedium. The cells were passaged at 80% confluence
by trypsinization (0.5% trypsin in 0.5 mMEDTA, Gibco BRL, Life
Technologies, Gaithersburg, MD).
C2C12 Cell Stimulation
C2C12 cells were seeded in 96-well plates (1.6 × 104 cells/well), 12-
well plates (5 × 104 cells/well), or six-well plates (4 × 105/well) in
the growth media and cultured for three days before changing to
differentiationmedia. The differentiation time points are calculated
as follows: D0 represent the cells that were collected 3 days after
seeding and have not received differentiation media; D3 cells
received differentiation media 3 days after seeding, and were
cultured for 3 days in differentiation media; D6 received
differentiation media 6 days after seeding, and were cultured for
6 days in differentiation media. Collected samples were subjected
on analysis of proliferation and viability (CKK-8 assay), apoptosis
and necrosis (AnnexinV/PI assay) and gene expression (qPCR).
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The experimental protocol is described as a flowchart in
Supplementary Figure S1A.
Experimental groups 1–4 represent the non-differentiated
myocytes, that were collected on differentiation day 0 (D0)
12 h after stimulations with TNFα, TNFα+ Met, TNFα+ CPX,
or left unstimulated.
Groups 5–8 were cultured for 3 days (D3) in differentiation
media, after which they were stimulated for 12 h with TNFα,
TNFα+ Met, TNFα+ CPX, or left unstimulated (Differentiation
media was changed on D1 and D2).
Groups 9–12 represent the fully differentiated myocytes that
were cultured for 6 days in differentiation media. D6 cells were
collected after 12 h stimulations with TNFα, TNFα+Met, TNFα+
CPX, or left unstimulated (Differentiation media was changed on
D3, D4, and D5).
All the above-mentioned treatments were applied on cells with
identical treatments with or without 1 h preincubation of the cells in
the presence of MCC950 (1 µM), which was left on the cells during
stimulations. Experiment media were collected for ELISA, and cell
lysates were subjected to western blot analysis (Supplementary
Figure S1B). Simultaneously cultured cells with Met or CPX
alone were analyzed for apoptosis by flow cytometry (FCM).
Cell Count Kit-8 (CCK-8) Assay
The cell count kit-8 (CCK-8), a rapid and highly sensitive
detection kit for cell proliferation and cytotoxicity, was used to
analyze the cell viability according to the manufacturer’s protocol
(Beyotime Corporation, Shanghai, China).
Apoptosis Detection
Cell apoptosis was detected with FCM. AnnexinV/PI apoptosis
detection kit was used according to the manufacturer’s protocols
(Beyotime Corporation, Shanghai, China). The method is based on
the cytofluorimetric assay established by Vermes et al. The kit
discriminates intact cells (Annexin-/PI-) from apoptotic (Annexin
+/PI−) and necrotic cells (Annexin +/PI+) (Vermes et al., 1995).
Quantitative Real-Time RT-PCR Analysis
C2C12 cells were harvested and their total cellular RNA was
purified using RNeasyMini Kit (QIAGEN, Düsseldorf, Germany)
according to the manufacturer’s instructions. Briefly, 1 μg of total
RNA was reverse transcribed using iScript cDNA Synthesis Kit
(BioRad Laboratories, Hercules, CA). Quantitative RT-PCR
(qPCR) was performed with 100 ng first-strand cDNA using
iQ SYBR Green Supermix (Bio-Rad Laboratories, Hercules,
CA) in iCycler iQ5 Multicolor Real-Time PCR Detection
System (Bio-Rad Laboratories, Hercules, CA). The copy
numbers of mRNA in the samples analyzed were determined
in triplicate and normalized against PBGD gene as an
endogenous control and the relative units were calculated
using the comparative Ct method. The following primers were
designed with the NCBI Primer Blast program:
Il1b sense primer (F, forward): 5′-GCAACTGTTCCTGAACTC
AACT-3′, anti-sense primer (R, reverse): 5′-ATCTTTTGGGGT
CCGTCAACT-3′; Nlrp3 sense primer (F, forward): 5′-ATTACC
CGCCCGAGAAAGG-3′, anti-sense primer (R, reverse): 5′-TCG
CAGCAAAGATCCACACAG-3′; MyoD1 sense primer (F,
forward): 5′-CCACTCCGGGACATAGACTTG-3′, anti-sense
primer (R, reverse): 5′-AAAAGCGCAGGTCTGGTGAG-3′;
Myogenin sense primer (F, forward): 5′-GAGACATCCCCCTAT
TTCTACCA-3′, anti-sense primer (R, reverse): 5′-GCTCAGTCC
GCTCATAGCC-3′; Myosin-2 sense primer (F, forward): 5′-GTC
AGCACCATGTCTTATGGG-3′, anti-sense primer (R, reverse): 5′-
TTTGCCAAATCGGGAAGAGTT-3′; PBGD sense primer (F,
forward): 5′-AGGTCGGTGTGAACGGATTTG-3′, anti-sense
primer (R, reverse): 5′-GGGGTCGTTGATGGCAACA-3′.
Western Blotting
Cells were lyzed in 150 µl of Mammal Cell Protein Extraction Reagent
(CWBiotech, Beijing, China). The total protein concentration was
determined with a Pierce BCA protein assay kit (Trans, Beijing,
China). For each sample 40 µg of protein was loaded and separated
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
consisting of 5% stacking gel and 12% resolving gel, and the
proteins were electrophoretically transferred to a polyvinylidene
fluoride (PVDF) membrane. The membranes were blocked with
5% nonfat milk in Tris-buffered saline (pH 7.4) containing 0.1%
Tween-20 (TBST). The membranes were incubated overnight at 4 °C
with mouse monoclonal antibodies against IL-1β (3A6, mouse mAb
#12242S, Cell Signaling Technology, Shanghai, China) in TBST with
5% nonfat milk. The secondary antibody goat anti-mouse IgG, HRP
conjugated (CW0102S, CWBiotech, Beijing, China) was used to
incubate the membrane for 2 h at room temperature (RT).
Labeling was performed using an enhanced chemiluminescence
(ECL) system (Thermo Fisher Scientific, Thermo, United States).
The density and area of the bands was quantitated.
ELISA Analyses
C2C12 cells were incubated in the presence of TNFα, with or
without Met or TNFα or MCC950 at day D0, D3, D6 for 24 h.
Mouse IL-1β concentrations in the cell culture media were
analyzed using a commercial enzyme-linked immunosorbent
assay (ELISA) kit according to the manufacturer’s protocols
(Sangon Biotech, Shanghai, China).
Statistical Analysis
Calculations were performed using GraphPad InStat3 for
Macintosh software. Overall significance level between the
stimulated and control groups or between stimulated and
inhibited groups was analyzed using one-way ANOVA, with the
Dunnett and Tukey-Kramer multiple comparisons tests when
appropriate. Statistical significance was set at p < 0.05. The data
are calculated as mean ± SEM of 12 samples (three repeated
experiments, each treatment performed in four replicates).
RESULTS
Effects of TNFa, and Modulation of H3R
Signaling on Myocyte Viability
The C2C12 cells were fully differentiated at D6 in each stimulation
(Figure 1A). During C2C12 myogenesis, TNFα decreased cell
viability at all the measured time points, days 0, 3, 6 (D0, D3,
D6), by 20.5% (p < 0.05), 29.8% (p < 0.05), and 29.7% (p < 0.05),
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respectively, as compared to the controls. Addition of H3R
antagonist ciproxifan (CPX) together with TNFα had no
additional effect on cell viability at the time points D0 and D3,
but further reduced the viability at time point D6 (40.3%, p < 0.05).
Meanwhile, addition of H3R agonist methimepip (Met) together
with TNFα had no additional effect on cell viability at any of the
time points of D0, D3, and D6 (Figure 1).
Inhibition of H3R Signaling Potentiates
TNFα-Induced Apoptosis
Met alone did not induce apoptosis, however, 15.3% of the cells
stimulatedwithCPXwere apoptotic (p< 0.05) at D6 (Figures 2A,B).
Next, we studied the effect of H3R inhibition on TNFα-induced
apoptosis. During C2C12 myogenesis, apoptosis and necrosis were
detected in 4–6.9% of the control cells. Compared to the control cells,
TNFα or TNFα +Met did not cause an obvious increase in apoptosis
or necrosis during myogenic differentiation (Figure 3). However,
treatment with combination of TNFα +CXP induced overall 61.3%
(p < 0.01) apoptotic cells on D6, among which early apoptosis was
observed in 29.9% (T  4.2, p < 0.05) of the cells and late apoptosis in
31.4% of the cells (T  5.0, p < 0.01) (Figure 3).
Expression of NLRP3 Receptor mRNA and
Myogenesis Markers
As previous study has shown that another proinflammatory cytokine,
IL-1β, induces the expression of Nlrp3 in C2C12 cells (Huang et al.,
FIGURE 1 | The effect of TNFα, Met and CXP on cell viability. (A): D6 C2C12 cells incubated in the presence of TNFa (20 ng/ml), TNFa + Met (100 nM) or TNFa +
CPX (1 µM) for 12 h and observed by phase contrast microscopy (100×). (B): Viability at D0, D3, and D6. C2C12 cells were incubated for 12 h in the presence of TNFa,
TNFa + Met or TNFa + CPX. The cell death was detected by cell count kit-8 assay; *p < 0.05, **p < 0.01 vs. control of the same differentiation day (black columns);
normalizing D0 ctrl  100%. There was no statistical difference when TNFa +Met or TNFa +CPXwas compared with TNFa-treatment of 0- and 3-differentiation day
(dark gray columns). Ctrl, control; TNFa, murine Tumor Necrosis Factor-alpha; Met, methimepip; CPX, ciproxifan. D0, undifferentiated cells; D3, cells differentiated for 3
days; D6, cells differentiated for 6 days.
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2017), we studied the involvement of theNLRP3 inflammasome in the
TNFα-induced inflammation. We analyzed the Nlrp3 expression
during C2C12 myogenesis on D0, D3 and D6. TNFα induced the
expression of Nlrp3mRNA up to 201% at D3 (p < 0.01) and 190% at
D6 (p < 0.01) as compared to the controls (Figure 4A). Met reduced
the TNFα-induced expression of Nlrp3 by 33% at D3 (p < 0.05) and
30% at D6 (p < 0.05), while CPX enhanced the effects of TNFα on
Nlrp3 expression by 24% (p < 0.05) at D6 (Figure 4A).
To study the effects of TNFα and H3R modulation in
myogenic differentiation, we analyzed the expression of the
conventional myogenic markers. Myogenic Differentiation 1
(MyoD1) is considered as one of the earliest myogenic
markers. MyoD1 is a nuclear protein that belongs to the
subfamily of myogenic factors, and it regulates muscle cell
differentiation by inducing cell cycle arrest, which is a
prerequisite for myogenic initiation (Blais et al., 2005).
Myogenin is usually regarded as an early myogenic marker. It
is a muscle-specific transcription factor that is involved in
coordination of skeletal muscle development or myogenesis
and repair, and it is essential for the development of
FIGURE 2 | The effect of histamine H3 receptor modulators on cell apoptosis and myogenesis. (A): Apoptotic cells were detected by flow cytometry using Annexin
V and propidium iodide staining; percentage of mechanically damaged cells (top left quadrant), live cells (bottom left), early apoptotic cells (bottom right), late
apoptotic cells (top right). (B): Percentage of apoptotic cells was calculated by adding the early and the late apoptotic cells for each experimental condition.*p < 0.05 vs.
control. (C): The C2C12myocytes were incubated in the presence of Met (100 nM) or CPX (1 μM) for 12 h at D6, and the effect of H3 receptor inhibition or activation
on myogenesis was assessed by analyzing the expression of the late myogenesis marker, myosin 2, mRNA by real time RT-PCR.*p < 0.05 vs. control of the same
differentiation day (black columns); normalizing D0 ctrl1. There was no statistical difference when Met or CPX was compared with control group (dark gray columns).
Ctrl, control; Met, methimepip; CPX, ciproxifan. D0, undifferentiated cells; D3, cells differentiated for 3 days; D6, cells differentiated for 6 days.
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functional skeletal muscle (Blais et al., 2005). Myosin heavy chain
2 (Myosin-2) is a late myogenic marker. It is a member of the class
II or conventional myosin heavy chains, and functions in skeletal
muscle contraction (Stuart et al., 2016). TNFα reduced the
expression of myogenesis markers: MyoD1 at D3 and D6 by
38% (p < 0.05) and 22% (p < 0.05) (Figure 4C), Myogenin at D3
FIGURE 3 | Inhibition of histamine H3 receptor enhances apoptosis. (A): C2C12 cells were incubated in the presence of TNFa (20 ng/ml), TNFa + Met (100 nM) or
TNFa + CPX (1 µM) at D0, D3, or D6. Apoptotic cells were detected by Annexin V and propidium iodide staining and analyzed by flow cytometry: percentage of cells
mechanically damaged (top left quadrant), live cells (bottom left), early apoptotic cells (bottom right), late apoptotic cells (top right). (B): Percentage of apoptotic
cells was calculated by adding the early and the late apoptotic cells for each experimental condition. **p < 0.01 vs. TNFα of the same differentiation day (dark gray
columns). Ctrl, control; TNFa, murine Tumor Necrosis Factor-alpha; Met, methimepip; CPX, ciproxifan. D0, undifferentiated cells; D3, cells differentiated for 3 days; D6,
cells differentiated for 6 days.
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and D6 by 29% (p < 0.05) vs. 35% (p < 0.05) (Figure 4B), and
Myosin-2 at D3 and D6 by 42% (p < 0.01) and 28% (p < 0.01)
(Figure 4D), respectively. Met enhanced the inhibitory effect of
TNFα of the above three markers by 23 and 31% (p < 0.05), 22
and 26%, 30% (p < 0.05) and 25% (p < 0.05) at D3 and D6,
respectively, while CPX reduced the inhibitory effect of TNFα on
the myogenic marker expression by 40% (p < 0.05) and 25%, 35%
(p < 0.05) and 37% (p < 0.05), 50% (p < 0.05) and 27% (p < 0.05)
(Figures 4B–D) respectively. Neither Met nor CPX alone had a
clear effect on the mRNA expression of the late myocyte
differentiation marker, myosin 2 (p > 0.05) (Figure 2C).
H3R Activation Regulates the Levels of
Mature IL-1β in TNFα-Treated Cells
To study the effects of TNFα and H3R modulation on the protein
expression IL-1β, we detected the levels of pro-IL-1β (31 kDa)
and IL-1β (17 kDa) proteins from cell lysates by western blot.
TNFα increased the levels of both the pro-IL-1β (31 kDa) and IL-
1β (17 kDa) proteins (p < 0.05), and neither Met nor CPX had an
effect on TNFα-induced pro-IL-1β expression in D0, D3 and D6
cells (p > 0.05). However, Met and CPX modulated the TNFα-
induced expression of mature IL-1β protein; Met reduced the
level of the mature IL-1β at all the time points (p < 0.05) in TNFα-
induced D0 and D6 cells, while CPX increased it (p < 0.05) at D0,
and D6 time points. MCC950, a new specific small molecule
NLRP3 inhibitor, reduced the pro-IL-1β (31 kDa) and mature IL-
1β (17 kDa) protein levels in each treatment group, except for
control group (p < 0.05) (Figure 5).
H3R Signaling Modulates the Secretion
of IL-1β
Since the secretion of mature IL-1β is a marker of inflammasome
activation, we next assessed the effect of TNFα and H3R modulation
on the inflammasome activation by analyzing IL-1β secretion during
C2C12 myogenesis. TNFα increased the secretion of IL-1β at D0, D3
and D6 cells to 56.8 (p < 0.01), 66.8 (p < 0.01), and 85.8 pg/ml (p <
0.01), respectively. Met reduced the TNFα-induced secretion of IL-1β
to 38.4 (p < 0.05), 48.4 (p < 0.05), 65.8 (p < 0.05) pg/ml, while CPX
enhanced the TNFα-induced secretion of IL-1β to 67.5 (p< 0.05), 77.5
(p < 0.05), 98.9 (p < 0.05) pg/ml on D0, D3 and D6 cells, respectively
(Figure 6). MCC950 reduced TNFα-induced IL-1β secretion to 41.2
(p < 0.05), 56.8 (p < 0.05), and 66.8 pg/ml (p < 0.05); and MCC950
reduced Met-TNFα-induced IL-1β secretion to 31.9 (p < 0.05), 38.4
(p < 0.05), 48.4 (p < 0.05) pg/ml. MCC950 reduced also CPX-TNFα-
induced IL-1β secretion to 49.8 (p < 0.05), 67.5 (p < 0.05), 77.5 (p <
0.05) pg/ml (Figure 6). Thus, our results suggest that H3R plays a role
in regulation of NLRP3 inflammasome. H3R inhibition reduces the
TNFα-induced secretion of IL-1β whereas H3R activation increases
IL-1β secretion in C2C12 myocytes. The secretion of IL-1β was
dependent on the NLRP3 inflammasome, as the NLRP3 inhibitor,
MCC950, reduced TNFα induced IL-1β secretion in each groups of
D0, D3 and D6 cells.
FIGURE 4 | The mRNA expression of inflammasome NLRP3 protein and myogenesis markers. C2C12 cells were incubated in the presence of TNFa (20 ng/ml),
TNFa + Met (100 nM) or TNFa + CPX (1 µM) for 12 h at D0, D3, or D6. The mRNA expressions were assessed by real time RT-PCR. *p < 0.05, and **p < 0.01 between
two compared groups. Normalizing D0 ctrl  1 after compared with housekeeping gene PBGD. (A): NLRP3 mRNA expression. (B) The mRNA expression of early
myogenesis marker, MyoD1. (C) The mRNA expression of intermediate myogenesis marker, Myogenin. (D) The mRNA expression of late myogenesis marker,
myosin 2. Ctrl, control; TNFa, murine Tumor Necrosis Factor-alpha; Met, methimepip; CPX, ciproxifan. D0, undifferentiated cells; D3, cells differentiated for 3 days; D6,
cells differentiated for 6 days. NLRP3, Nucleotide-binding domain and leucine-rich repeat containing family, pyrin domain containing three.
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FIGURE 5 | NLRP3 inhibitor, MCC950, inhibited overall pro-IL-1β and IL-1β protein levels induced by TNFα. C2C12 cells were incubated in the presence of TNFa
(20 ng/ml), TNFa + Met (100 nM) or TNFa + CPX (1 µM) or overall MCC950 (1 µM) for 12 h at D0, D3, or D6. The pro-IL-1β (31 kDa) and mature IL-1β protein (17 kDa)
levels were assessed by westernblot. *p < 0.05, and **p < 0.01 between two compared groups. (A,B): The grey-values of westernblot on pro-IL-1β and IL-1β proteins at
D0 were calculated by normalized protein expressions to β-actin. (C,D): The grey-values of westernblot on pro-IL-1β and IL-1β proteins at D3 were calculated by
normalized protein expressions to β-actin. (E,F): The grey-values of westernblot on pro-IL-1β and IL-1β proteins at D6were calculated by normalized protein expressions
to β-actin. Ctrl, control; TNFa, murine Tumor Necrosis Factor-alpha; Met, methimepip; pro-IL-1β, the precursor of interleukin 1beta; IL-1β, interleukin 1beta; CPX,
ciproxifan. D0, undifferentiated cells; D3, cells differentiated for 3 days; D6, cells differentiated for 6 days.
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DISCUSSION
Inflammation is an immunological response to injury and the
concomitant release of damage associated molecular patterns
(Hofer et al., 2014). The underlying molecular mechanisms are
complex but recent studies implicate activation of inflammasomes
in sterile inflammatory reactions (Mangan et al., 2018). The present
study verified the presence of functional NLRP3-inflammasome in
mouse striated C2C12 myocytes (Cho and Kang, 2015; Gallo et al.,
2015). TNFα induced both the expressions of pro-IL-1β and also
the activation of NLRP3 inflammasome in C2C12 myocytes
resulting in secretion of the mature IL-1β protein. TNFα also
reduced cell viability and the expression of myogenesis markers,
suggesting that it inhibited myocyte differentiation. These findings
are in line with previous studies which have shown that IL-1β
induces markers of atrophy in C2C12 cells (Huang et al., 2017).
Together these findings suggest that TNFα mediated
inflammasome activation with ensuing IL-1β secretion could
play an important role in postinjury muscle inflammation and
inflammation associated muscle atrophy.
Stimulation of H3R signaling by Met attenuated the TNFα-induced
activation of NLRP3 inflammasome, whereas, inhibition of H3R
signaling enhanced the inflammasome activation by TNFα. Recently
Gao et al. showed that loratadine, a histamine H1 receptor blocker,
inhibits the activation of NLRP3 inflammasome (Gao and Zhang,
2020), but there are no studies addressing the role of H3R in regulation
of NLRP3 inflammasome. The effect of TNFα on myogenic
differentiation is affected by the conditions used and also on
concentration of TNFα. Low levels of TNFα are required for the
differentiation, but on the other hand, especially at higher concentration,
such as during inflammation, TNFα has been shown to increase
myoblast proliferation, and to prevent the cells entering to cell cycle
arrest that is a prerequisite for the initiation of myoblast differentiation
(Grounds and Torrisi, 2004; Chen et al., 2007; Alter et al., 2008). TNFα
reduced the expression of the earliest differentiation markers on the
earlier day three time point slightly more than at later sixth day time
point. The differences between the time points are probably explained
by the number of the cells that have entered the cell cycle arrest before
TNFα treatment, becauseTNFα does not inhibit the differentiation after
the cells have entered the cell cycle arrest (Alter et al., 2008), and by day
sixmore cells had entered the cell cycle arrest and started differentiation
than by day three, and probably therefore the effect of TNFα on
differentiation was slightly mitigated.
Activation of H3R further slowed myogenic differentiation in the
presence of TNFα. The mechanism remains to be elucidated but one
possibility is that H3R activation directs cell resources into processes
of reducing inflammation, thus halting the differentiation. In
carcinoma cells H3R -mediated activation of protein kinase C α
inhibited the growth of cholangiocarcinoma and hepatocellular
carcinoma cells (Francis et al., 2009; Yu et al., 2019). The finding
that blocking theH3R byCPX in the presence of TNFα enhanced cell
differentiation, is also in line with studies on cancer cells reporting
that inhibition of histamine receptor H3 suppresses the growth and
metastasis in human non-small cell lung cancer cells (Zhao et al.,
2020) thus potentially promoting differentiation. Moreover, the
enhanced inflammation induced by CPX + TNFα could also
direct cells into apoptosis resulting in the release of ATP, which
further activates the NLRP3 inflammasome (Jo et al., 2016).
CONCLUSION
TNFα induces NLRP3 inflammasome activation and inhibits
myogenesis in striated C2C12 cells during myogenic
FIGURE 6 | Histamine H3 receptor modulates the secretion of IL-1β.
C2C12 cells were incubated in the presence of TNFa (20 ng/ml), TNFa + Met
(100 nM) or TNFa + CPX (1 µM) or MCC950 (1 µM) for 24 h at D0, D3, or D6.
The mature IL-1β protein secretions were assessed by ELISA. *p < 0.05,
and **p < 0.01 between two compared groups. (A): IL-1β secretion in D0 cells.
(B) IL-1β secretion in D3 cells. (C) IL-1β secretion in D6 cells. Ctrl, control;
TNFα, murine Tumor Necrosis Factor-alpha; Met, methimepip; CPX,
ciproxifan; IL-1β, interleukin 1beta.
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differentiation. Histamine H3R signaling slowed the differentiation
and inhibited TNFα induced NLRP3 inflammasome activation.
Inhibition of H3R signaling enhanced the differentiation and
TNFα-induced inflammation. These findings implicate a
regulatory role for histamine H3R in NLRP3 inflammasome
activation. This beneficial effect of H3R activation should be
balanced with the potentially disadvantageous effect of further
slowing down themyocyte differentiation in the presence of TNFα.
H3R modulation could represent a lucrative target in the treatment
of postinjury muscle inflammation and atrophy.
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